212 related articles for article (PubMed ID: 23392942)
1. Influence of taurine haloamines (TauCl and TauBr) on the development of Pseudomonas aeruginosa biofilm: a preliminary study.
Marcinkiewicz J; Strus M; Walczewska M; Machul A; Mikołajczyk D
Adv Exp Med Biol; 2013; 775():269-83. PubMed ID: 23392942
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
[TBL] [Abstract][Full Text] [Related]
3. Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide.
Marcinkiewicz J; Mak M; Bobek M; Biedroń R; Białecka A; Koprowski M; Kontny E; Maśliński W
Inflamm Res; 2005 Jan; 54(1):42-9. PubMed ID: 15723204
[TBL] [Abstract][Full Text] [Related]
4. Taurine bromamine (TauBr)--its role in immunity and new perspectives for clinical use.
Marcinkiewicz J
J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S3. PubMed ID: 20804605
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of taurine haloamines and chlorhexidine against selected oral microbiome species].
Pasich E; Bialecka A; Marcinkiewicz J
Med Dosw Mikrobiol; 2013; 65(3):187-96. PubMed ID: 24432558
[TBL] [Abstract][Full Text] [Related]
6. Taurine Haloamines and Biofilm. Part I: Antimicrobial Activity of Taurine Bromamine and Chlorhexidine Against Biofilm Forming Pseudomonas aeruginosa.
Strus M; Walczewska M; Machul A; Mikołajczyk D; Marcinkiewicz J
Adv Exp Med Biol; 2015; 803():121-32. PubMed ID: 25833493
[No Abstract] [Full Text] [Related]
7. Taurine Haloamines and Biofilm: II. Efficacy of Taurine Bromamine and Chlorhexidine Against Selected Microorganisms of Oral Biofilm.
Pasich E; Walczewska M; Białecka A; Peruń A; Kasprowicz A; Marcinkiewicz J
Adv Exp Med Biol; 2015; 803():133-43. PubMed ID: 25833494
[No Abstract] [Full Text] [Related]
8. The role of heme oxygenase-1 in down regulation of PGE2 production by taurine chloramine and taurine bromamine in J774.2 macrophages.
Olszanecki R; Kurnyta M; Biedroń R; Chorobik P; Bereta M; Marcinkiewicz J
Amino Acids; 2008 Aug; 35(2):359-64. PubMed ID: 18157587
[TBL] [Abstract][Full Text] [Related]
9. Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages.
Olszanecki R; Marcinkiewicz J
Amino Acids; 2004 Aug; 27(1):29-35. PubMed ID: 15309569
[TBL] [Abstract][Full Text] [Related]
10. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
11. Modification of IkappaBalpha by taurine bromamine inhibits tumor necrosis factor alpha-induced NF-kappaB activation.
Tokunaga S; Kanayama A; Miyamoto Y
Inflamm Res; 2007 Nov; 56(11):479-86. PubMed ID: 18224289
[TBL] [Abstract][Full Text] [Related]
12. Taurine bromamine: a new therapeutic option in inflammatory skin diseases.
Marcinkiewicz J
Pol Arch Med Wewn; 2009 Oct; 119(10):673-6. PubMed ID: 19847145
[TBL] [Abstract][Full Text] [Related]
13. Taurine haloamines and heme oxygenase-1 cooperate in the regulation of inflammation and attenuation of oxidative stress.
Marcinkiewicz J; Walczewska M; Olszanecki R; Bobek M; Biedroń R; Dulak J; Józkowicz A; Kontny E; Maślinski W
Adv Exp Med Biol; 2009; 643():439-50. PubMed ID: 19239176
[TBL] [Abstract][Full Text] [Related]
14. Taurine and inflammatory diseases.
Marcinkiewicz J; Kontny E
Amino Acids; 2014 Jan; 46(1):7-20. PubMed ID: 22810731
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Selected Iminosugar Derivatives on Pseudomonas aeruginosa Biofilm Formation.
Strus M; Mikołajczyk D; Machul A; Heczko PB; Chronowska A; Stochel G; Gallienne E; Nicolas C; Martin OR; Kyzioł A
Microb Drug Resist; 2016 Dec; 22(8):638-645. PubMed ID: 27031025
[TBL] [Abstract][Full Text] [Related]
16. Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.
Marcinkiewicz J; Nagl M; Kyriakopoulos A; Walczewska M; Skóra M; Skalska P
Adv Exp Med Biol; 2022; 1370():83-98. PubMed ID: 35882784
[TBL] [Abstract][Full Text] [Related]
17. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
Tolker-Nielsen T
APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
[TBL] [Abstract][Full Text] [Related]
19. The role of bacterial biofilms in chronic infections.
Bjarnsholt T
APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
[TBL] [Abstract][Full Text] [Related]
20. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
